EC Gastroenterology and Digestive System

Research Article Volume 9 Issue 8 - 2022

Real Time Artificial Intelligence-Aided Colonoscopy Experience: The Impact on Routine Clinical Practice in a High-Volume Center

Simona Agazzi1*, Chicco F1, Scudeller L3, Marzo V1, Rosa C1, Rossi G1, Guizzetti GG2 and Alvisi C1

1Digestive Endoscopy Unit, ASST Pavia, Italy

2Clinical Engineering Unit, ASST Pavia, Italy

3Research and Innovation Unit, IRCCS Azienda Ospedaliero-Universitaria Bologna, Italy

*Corresponding Author: Simona Agazzi, Digestive Endoscopy Unit, ASST Pavia, Italy.
Received: February 28, 2022; Published: July 29, 2022



Background: Advent of Artificial Intelligence (AI) with the development of computer-aided polyp detection (CADe) could be an important support against colorectal cancer (CRC). Our primary aim was to estimate polyp detection rate (PDR) and adenoma detection rate (ADR) improvement in CADe colonoscopy (CAD-EYE, Fujifilm, Tokyo, Japan) when compared to traditional colonoscopy, and to assess how these results could impact on our clinical activity.

Materials and Methods: We retrospectively collected data from all consecutive 40-to80-years old subjects undergoing colonoscopy for primary CRC screening, post-polypectomy surveillance or the presence of any gastrointestinal symptoms from November 2019 to February 2020 (WL-HD colonoscopy, control arm, 450 patients) and from October 2020 to January 2021 (CAD-EYE colonoscopy, study arm, 250 patients).

Results: Higher PDR (159/250 [63.60%] vs 163/450 [36.22%]; p < 0,001) and ADR (115/250 [46%]

vs 138/450 [30,67%]; p < 0,001) was found in the CADe group in comparison to the control group. CADe colonoscopy detected more lesions, especially diminutive lesions (RRR 5.07; 95% CI 3.44 - 7.46; p < < 0.001001) and 6 - 9 mm lesions (RRR 2,75; 95% CI 1.64 - 4.60; p < 0.001).

Regarding lesions’ histology, CADe is associated to a higher detection of non-advanced adenomas (RRR 2.97; 95% CI 2.02 - 4.38; p < 0.001) and serrated lesions (RRR 14.02; 95% CI 5.37 - 36.62; p < 0.001), while no significant improvement was found for advanced adenomas (RRR 1.35; 0.34 - 5.34; p = 0.667) and adenocarcinomas (RRR 1.3; 95% CI 0.52-3.23; 0.574).

Conclusion: Our study showed a 75,6% and 49,98% relative increase in PDR and ADR in the CADe group (absolute increase of 27,38% and 15,33% respectively). Real-time AI-aided colonoscopy applied in the routine endoscopic activity could significantly improve diagnostic ability especially for diminutive lesions detection. Further studies are needed to evaluate a possible colon cancer incidence reduction following AI-colonoscopy increased ADR.

Keywords: Artificial Intelligence (AI); Computer-Aided Polyp Detection (CADe); Colorectal Cancer (CRC); Polyp Detection Rate (PDR); Adenoma Detection Rate (ADR)

  1. H Sung., et al. “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA: A Cancer Journal for Clinicians 3 (2021): 209-249.
  2. NN Keum and E Giovannucci. “Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies”. Nature Reviews Gastroenterology and Hepatology 12 (2019): 713-732.
  3. P Hewitson., et al. “Screening for colorectal cancer using the faecal occult blood test, Hemoccult”. Cochrane Database of Systematic Reviews 1 (2007): CD001216.
  4. CA Doubeni., et al. “Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: A large community-based study”. Gut 2 (2018): 291-298.
  5. MF Kaminski., et al. “Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative”. United European Gastroenterology Journal 3 (2017): 309-334.
  6. MF Kaminski., et al. “Increased Rate of Adenoma Detection Associates with Reduced Risk of Colorectal Cancer and Death”. Gastroenterology1 (2017): 98-105.
  7. FU Ertem., et al. “Incidence of interval colorectal cancer attributable to an endoscopist in clinical practice”. Gastrointestinal Endoscopy 4 (2018): 705-711.e1.
  8. S Zhao., et al. “Magnitude, Risk Factors, and Factors Associated with Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis”. Gastroenterology 6 (2020): 1661-1674.e11.
  9. A Repici., et al. “Efficacy of Real-Time Computer-Aided Detection of Colorectal Neoplasia in a Randomized Trial”. Gastroenterology 2 (2020): 512-520.e7.
  10. P Wang., et al. “Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADe-DB trial): a double-blind randomised study”. Lancet Gastroenterology and Hepatology 4 (2020): 343-351.
  11. C Hassan., et al. “Performance of artificial intelligence in colonoscopy for adenoma and polyp detection: a systematic review and meta-analysis”. Gastrointestinal Endoscopy 1 (2021): 77-85.e6.
  12. M Stolte. “Vienna classification of gastrointestinal epithelial neoplasia”. Japanese Journal of Gastroenterology 96 (1999): A387-A389.
  13. P Wang., et al. “Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: A prospective randomised controlled study”. Gut 10 (2019): 1813-1819.
  14. JR Su., et al. “Impact of a real-time automatic quality control system on colorectal polyp and adenoma detection: a prospective randomized controlled study (with videos)”. Gastrointestinal Endoscopy 2 (2020): 415-424.e4.
  15. WN Liu., et al. “Study on detection rate of polyps and adenomas in artificial- intelligence-aided colonoscopy”. Saudi Journal of Gastroenterology 1 (2020): 13-19.
  16. I Barua., et al. “Artificial intelligence for polyp detection during colonoscopy: A systematic review and meta-analysis”. Endoscopy 3 (2021): 277-284.
  17. S Attardo., et al. “Artificial intelligence technologies for the detection of colorectal lesions: The future is now”. World Journal of Gastroenterology 37 (2020): 5606-5616.
  18. SC Van Doorn., et al. “Polyp morphology: An interobserver evaluation for the Paris classification among international experts”. American Journal of Gastroenterology 1 (2015): 180-187.
  19. E Dekker., et al. “Colorectal Cancer Screening in the Novel Coronavirus Disease- 2019 Era”. Gastroenterology 6 (2020): 1998-2003.
  20. P Mantellini., et al. “Rapporto sui ritardi accumulati dai programmi di screening italiani in seguito alla pandemia da Covid-19. Secondo Rapporto al 30 Settembre 2020 La survey quantitativa Risultati” (2020).
  21. T Murakami., et al. “Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma”. World Journal of Gastroenterology 29 (2018): 3250-3259.
  22. B Leggett and V Whitehall. “Role of the Serrated Pathway in Colorectal Cancer Pathogenesis”. Gastroenterology6 (2010): 2088-2100.

Simona Agazzi., et al. Real Time Artificial Intelligence-Aided Colonoscopy Experience: The Impact on Routine Clinical Practice in a High-Volume Center. EC GASTROENTEROLOGY AND DIGESTIVE SYSTEM 9.8 (2022): 80-89.